{
    "pmid": "41454602",
    "title": "VEGF-A splicing variant in plasma is a predictive potential biomarker of bevacizumab in advanced non-squamous non-small cell lung cancer.",
    "abstract": "Bevacizumab is a monoclonal antibody targeting vascular endothelial growth factor-A (VEGF-A), a key mediator of tumor angiogenesis. Among VEGF-A splice variants, VEGF-A",
    "disease": "lung cancer",
    "clean_text": "vegf a splicing variant in plasma is a predictive potential biomarker of bevacizumab in advanced non squamous non small cell lung cancer bevacizumab is a monoclonal antibody targeting vascular endothelial growth factor a vegf a a key mediator of tumor angiogenesis among vegf a splice variants vegf a"
}